[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"live-birth-rate\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:live-birth-rate":32},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,59,108],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":35,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":58},"100528791","hyaluronan-enriched-medium-and-euploid-blastocyst-transfers-100528791",false,"NCT06165367","Hyaluronan-enriched Medium and Euploid Blastocyst Transfers","Impact of Hyaluronan-enriched Medium on Pregnancy Outcomes Following Euploid Blastocyst Transfers","GluePloid","Inclusion Criteria:\n\n* All frozen embryo transfer (FET) cycles with euploid blastocysts biopsied and vitrified on Day 5 after PGT-A.\n* Rank of randomization based on embryo quality.\n* Only hormonal replacement theraphy (HRT) cycle regimen.\n* Women aged 18 years to 46 years.\n* Having at least 1 chromosomally normal vitrified blastocyst(s) on Day 5 available for transfer.\n* All sperm samples.\n* BMI between 18 and 35.\n\nExclusion Criteria:\n\n* FET cycles with preimplantation genetic testing for monogenic disorders (PGT-M) and for structural rearrangements (PGT-SR).\n* FET cycles with mosaic \u002F aneuploid blastocysts.\n* FET cycles with unknown outcome.\n* FET cycles with Day 6 or Day 7 biopsied blastocysts.\n* FET with patients' endometrium preparation with treatments other than HRT.\n* FET where PGT-A was performed for gender selection.",true,"FEMALE","18 Years","46 Years",{"count":22,"type":23},783,"ESTIMATED","INTERVENTIONAL",[26],"NA","It has been proposed that enriching transfer media with hyaluronan (EmbryoGlue medium) improves pregnancy outcomes compared with media containing lower concentrations of this molecule. However, none of previous studies included preimplantation genetic testing for aneuploidy (PGT-A) embryos. In order to investigate the impact of this hyaluronan-enriched on pregnancy outcomes, it is essential to evaluate its efficacy on euploid-only embryo transfers. The aim of the present study is to evaluate whether a short period of exposure of euploid blastocysts to EmbryoGlue prior to and during transfer positively impact on pregnancy outcomes of frozen embryo transfer (FET) cycles.",[29,30,31,32,33,34],"Infertility","Implantation Rate","Clinical Pregnancy Rate","Live Birth Rate","Blastocysts","FET",[36,37,38,39,40,41,42,43,44,45],"HRT","PGT-A","Next-generation sequencing (NGS)","Miscarriage rate","single embryo transfer (SET)","EmbryoGlue","BMI","Embryo quality","Hyaluronan-enriched medium","Transfer medium","RECRUITING","2026-06-22",{"date":49,"type":50},"2026-06-25","ACTUAL",{"date":52,"type":50},"2024-01-15",{"date":54,"type":23},"2026-12-31",{"name":56,"class":57},"ART Fertility Clinics LLC","OTHER",1,{"id":60,"slug":61,"hasResults":11,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":11,"sex":66,"minAge":19,"maxAge":67,"enrollmentInfo":68,"targetDuration":70,"studyType":71,"phases":4,"briefSummary":72,"conditions":73,"keywords":86,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":58},"100616933","long-term-evaluation-of-fertility-preservation-options-in-women-in-cancer-remission-or-haematological-pathology-100616933","NCT07312058","Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology","FERT-ISSUES","Inclusion Criteria:\n\n* Women\n* Aged between 18 and 47 years\n* Diagnosed with cancer or hematological disorders requiring potentially gonadotoxic treatment\n* Having undergone a medical fertility preservation consultation\n* Followed at Amiens Picardie University Hospital (CHU Amiens Picardie) in the department of Reproductive Medicine\n* Currently in remission\n* Having expressed non-opposition to participation in the study\n\nExclusion Criteria:\n\n* Absence of remission\n* Patients deprived of liberty by administrative or judicial decision, or placed under legal protection (guardianship or curators)\n* Decline to participate in the study","ALL","47 Years",{"count":69,"type":23},102,"1 Day","OBSERVATIONAL","Cancer treatments, despite their increasing effectiveness, carry a significant risk of gamete toxicity.\n\nWomen of reproductive age are commonly offered fertility preservation (FP) before starting their treatment.\n\nHowever, few studies have analyzed the long-term reproductive outcomes of these interventions, nor how patients ultimately use or do not use the FP options once in remission.\n\nThis project aims to better understand the effectiveness, utilization, and psychological impacts of these strategies.\n\nThis work is part of an effort to understand and evaluate fertility preservation practices implemented for women of reproductive age undergoing cancer treatment at the Amiens-Picardie University Hospital (CHU).\n\nIts objective is to document patient pathways, clinical decisions, techniques employed, and reproductive outcomes observed after remission, in order to identify potential areas for improvement in the support and follow-up of these patients, thereby enhancing the overall quality and coordination of care.\n\nThis work is conducted alongside the development of a fertility observatory at the Department of Medicine and Reproductive Biology, CHU Amiens-Picardie.",[74,75,76,77,78,79,80,81,82,83,84,85,32],"Fertility Preservation","Cancer Remission","Reproductive Outcomes","Reproductive Health","Oncology","Fertility Counseling","Assisted Reproductive Technology","Psychological Impact","Fertility Observatory","Patient Follow-up","Female Cancer Survivors","Fertility Preservation Techniques",[87,88,89,90,78,91,92,93,94,95,96,97,98],"Fertility preservation","Cancer remission","Reproductive outcomes","Reproductive health","Fertility counseling","Assisted reproductive technology","Psychological impact","Fertility observatory","Patient follow-up","Female cancer survivors","Fertility preservation techniques","Live birth rate","2026-01-15",{"date":101,"type":50},"2026-01-16",{"date":103,"type":23},"2025-12-17",{"date":105,"type":23},"2027-01",{"name":107,"class":57},"Centre Hospitalier Universitaire, Amiens",{"id":109,"slug":110,"hasResults":11,"nctId":111,"briefTitle":112,"officialTitle":112,"acronym":113,"eligibilityCriteria":114,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":115,"enrollmentInfo":116,"targetDuration":118,"studyType":71,"phases":4,"briefSummary":119,"conditions":120,"keywords":122,"overallStatus":125,"whyStopped":4,"lastUpdateSubmitDate":126,"lastUpdatePostDateStruct":127,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":58},"100613527","uterine-interstitial-myolisis-and-oocytes-retrieval-in-single-step-a-pilot-study-100613527","NCT07267754","Uterine Interstitial Myolisis and Oocytes Retrieval in Single Step: a Pilot Study","UIMandOPU","Inclusion Criteria:\n\nInfertile women with uterine fibroids who need to undergo oocytes retrieval between 18 and 45years old\n\nExclusion Criteria:\n\nFertile woman with uterine fibroids Fertile women without uterine fibroids Women under 18 years old Woman over 45 years old\n\n\\-","45 Years",{"count":117,"type":23},20,"2 Years","The aim of this observational cohort study is to evaluate the pregnancy rate, the ongoing pregnancy rate and the live birth rate of infertile women aged between 18 and 45 years who undergo a single surgical step of oocyte retrieval and uterine interstitial myolisis .\n\nThe main questions of these study are:\n\n1. What is the chances of a positive pregnancy test and what is the chances of live birth for women who undergo oocyte retrieval and interstitial myolysis in a single surgical step?\n2. Are there any complications associated with performing the two surgical techniques at the same time? Researchers will calculate IVF\u002FICSI outcomes after embryotransfer of vitrified blastocystis obtained after oocyte retrieval and subsequent interstitial myolysis.\n\nWomen undergoing oocyte retrieval will agree to undergo oocyte retrieval and interstitial myolysis at the same time, to freeze their blastocysts and to transfer them into the uterus after 6 months",[121,31,32],"Pregnancy Rate IVF",[123,124,80],"Oocyte retrieval","Interstitial myolysis","NOT_YET_RECRUITING","2025-11-25",{"date":128,"type":50},"2025-12-05",{"date":130,"type":23},"2026-01-01",{"date":132,"type":23},"2027-01-30",{"name":134,"class":57},"San Carlo Public Hospital, Potenza, Italy"]